Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen

• Peter J. Hart,

  Affiliation School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Colette M. O’Shaughnessy,

  Affiliation School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Matthew K. Siggins,

  Affiliation School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Saeeda Bobat,

  Affiliation School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Robert A. Kingsley,

  Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  ⨯
• David A. Goulding,

  Affiliation Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom

  ⨯
• John A. Crump,

  Affiliations Centre for International Health, University of Otago, Dunedin, New Zealand, Kilimanjaro Christian Medical Centre and Kilimanjaro Christian Medical University College, Tumaini University, Moshi, Tanzania, Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, United States of America, Duke Global Health Institute, Duke University, Durham, United States of America

  ⨯
• Hugh Reyburn,

  Affiliation London School of Hygiene and Tropical Medicine, Keppel Street, London, United Kingdom

  ⨯
• Francesca Micoli,

  Affiliation Sclavo-Behring Vaccines Institute for Global Health, a GlaxoSmithKline Company, Siena, Italy

  ⨯
• Gordon Dougan,

  Affiliation Centre for International Health, University of Otago, Dunedin, New Zealand

  ⨯
• Adam F. Cunningham,

  Affiliation School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom

  ⨯
• Calman A. MacLennan

  * E-mail: calman.maclennan@ndm.ox.ac.uk

  Affiliations School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom, Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

  ⨯